News

The decision follows Sandoz’s submission of an abbreviated new drug application (ANDA) seeking marketing authorization of the generic version of AzaSite before expiration of the patents covering AzaSite

The survey showed that while many patients felt that a personalized targeted approach was not discussed, the majority of patients (62%) agreed that decisions about how to treat

The Phase 2a trial is intended to recruit around 84 patients who are suffering from chronic HCV genotypes 1, 2 or 3 who have not been treated previously.

The data from randomized, double blind, controlled multi-center clinical trials of Atopiclair in adults, children and, infants aged over 6 months, showed relief and control of the symptoms

Under the agreement, CPC expects to manage and oversee the activities of the Eligibility Review Committee, which will be responsible to identify and confirm the eligibility of no-option

The new company’s product portfolio comprises medicines targeting treatment of inflammatory diseases and conditions including atopic dermatitis, dry eye syndrome, interstitial cystitis, and lymphatic disorders, as well as

The study results demonstrated that the addition of Cimzia to current therapy showed rapid and consistent efficacy across the patients taking certolizumab pegol whether they had previously received

The study is a placebo-controlled, double-blinded, single site Phase I trial which involves 24 healthy women randomized in two groups to monitor the safety and immunogenicity of the

The company expects to disclose the results within eight weeks. Heplisav is an experimental adult hepatitis B vaccine which is evaluated in two Phase 3 studies that are